Background: Major depressive disorder (MDD) is often a chronic disorder with relapses usually detected and managed in primary care using a validated depression symptom questionnaire. However, for individuals with recurrent depression the choice of which questionnaire to use and whether a shorter measure could suffice is not established. Aim: To compare the nine-item Patient Health Questionnaire (PHQ-9), the Beck Depression Inventory, and the Hospital Anxiety and Depression Scale against shorter PHQ-derived measures for detecting episodes of DSM-IV major depression in primary care patients with recurrent MDD. Design and setting: Diagnostic accuracy study of adults with recurrent depression in primary care predominantly from Wales. M...
Background: Prevalence estimates for depression vary considerably by the type of assessment instr...
Background: Major depressive disorder (MDD) may be present in 10%-20% of patients in medical setting...
Background: Major depressive disorder (MDD) may be present in 10%–20% of patients in medical setting...
Background: Major depressive disorder (MDD) is often a chronic disorder with relapses usually detect...
Abstract Background There is a need for brief instruments to ascertain the diagnosis of major depres...
Item does not contain fulltextOBJECTIVE: Only half of patients with depressive disorder are diagnose...
BACKGROUND: The next generation of studies on antidepressant drug prescriptions in general practice...
Background: Depression is common among type 2 diabetes mellitus (DM2)/coronary heart disease (CHD) p...
Background: Depression is a leading cause of disability. International guidelines recommend screenin...
Background: Depression is a leading cause of disability. International guidelines recommend screenin...
出版社版 オープンアクセスOBJECTIVE: The Patient Health Questionnaire (PHQ-9) is a self-report questionnaire com...
Abstract Background The prevalence of major depressive disorder (MDD) in Spanish primary care (PC) c...
Background: Several factors need to be considered when selecting a screening tool for depression inc...
Abstract Background About one in five patients with depression experiences a chronic course. Despite...
Abstract Background: The Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief self-report consi...
Background: Prevalence estimates for depression vary considerably by the type of assessment instr...
Background: Major depressive disorder (MDD) may be present in 10%-20% of patients in medical setting...
Background: Major depressive disorder (MDD) may be present in 10%–20% of patients in medical setting...
Background: Major depressive disorder (MDD) is often a chronic disorder with relapses usually detect...
Abstract Background There is a need for brief instruments to ascertain the diagnosis of major depres...
Item does not contain fulltextOBJECTIVE: Only half of patients with depressive disorder are diagnose...
BACKGROUND: The next generation of studies on antidepressant drug prescriptions in general practice...
Background: Depression is common among type 2 diabetes mellitus (DM2)/coronary heart disease (CHD) p...
Background: Depression is a leading cause of disability. International guidelines recommend screenin...
Background: Depression is a leading cause of disability. International guidelines recommend screenin...
出版社版 オープンアクセスOBJECTIVE: The Patient Health Questionnaire (PHQ-9) is a self-report questionnaire com...
Abstract Background The prevalence of major depressive disorder (MDD) in Spanish primary care (PC) c...
Background: Several factors need to be considered when selecting a screening tool for depression inc...
Abstract Background About one in five patients with depression experiences a chronic course. Despite...
Abstract Background: The Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief self-report consi...
Background: Prevalence estimates for depression vary considerably by the type of assessment instr...
Background: Major depressive disorder (MDD) may be present in 10%-20% of patients in medical setting...
Background: Major depressive disorder (MDD) may be present in 10%–20% of patients in medical setting...